NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Subjects Medicare Part B -- economics Remove constraint Subjects: Medicare Part B -- economics

Search Results

21. Medicare Part B drug payments: impact of price substitutions based on 2018 average sales prices

22. Some manufacturers reported inaccurate drug product data to CMS

25. COVID-19 tests drove an increase in total Medicare Part B spending on lab tests in 2020, while use of non-COVID-19 tests decreased significantly

26. High-expenditure Medicare drugs often qualified for Orphan Drug Act incentives designed to encourage the development of treatments for rare diseases

27. Medicare Part B drug payments: impact of price substitutions based on 2017 average sales prices

28. CBO's Medicare beneficiary cost-sharing model: a technical description

29. Medicare Part B drugs: trends in spending and utilization, 2008-2021